BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Harvard Bioscience Completes Genomics Solutions Acquisition

Oct. 28, 2002
By Aaron Lorenzo

OSI Drops Diabetes Program, Puts Full Focus On Oncology

Oct. 25, 2002
By Aaron Lorenzo

OSI Drops Diabetes Program, Puts Full Focus On Oncology

Oct. 25, 2002
By Aaron Lorenzo

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Oct. 24, 2002
By Aaron Lorenzo

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Oct. 24, 2002
By Aaron Lorenzo

Incara Divests Liver Program Via Sale To Vesta Therapeutics

Oct. 23, 2002
By Aaron Lorenzo

Incara Divests Liver Program Via Sale To Vesta Therapeutics

Oct. 23, 2002
By Aaron Lorenzo

ICOS, Texas Biotechnology Plan FDA Meeting On PAH Drug

Oct. 22, 2002
By Aaron Lorenzo

ICOS, Texas Biotechnology Plan FDA Meeting On PAH Drug

Oct. 22, 2002
By Aaron Lorenzo

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Oct. 8, 2002
By Aaron Lorenzo
Previous 1 2 … 220 221 222 223 224 225 226 227 228 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing